事業内容
あなたはここにいる:ホーム > 事業内容
Our structural biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.
Medicilon's team integrates expertise in Kinase Services with deep knowledge of regulatory, market access and commercial global pathways. This service was designed to meet your specific needs fast at extremely competitive prices. We can also provide screening services on specified signaling pathways areas in accordance to your needs.
Medicilon has over 100 well-characterized Tumor Cell Line Xenograft models. Our experienced staffs operate with strong theoretical basis. We offer the services which are flexible for custom development of various types of models to meet the requirements of our clients.
Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.
Medicilon offers syngeneic mouse models suitable for the evaluation of immunobiological-based therapies.
Medicilon provides transgenic mouse services.One-stop solution to generate transgenic mouse models and embryos.Complete selection of full-service or customizable packages for genetically-modified rodent model generation and colony management.
Humanized mouse models are primarily used to assess the efficacy of drugs and therapies. They are also used to create models that can generate reproducible results. A humanized mouse is referred to as a mouse transmitting functioning human organs, tissues, cells, and genes. Humanized mice are basically employed in medical and biological therapeutics as animal models.
PDX models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds. We offer a range of preclinical cancer models (subcutaneous tumor xenografts, orthotropic tumor models, orthotopic tumor model, syngeneic model ,etc.).